Integrated Resistance Analysis of CERTAIN-1 and CERTAIN-2 Studies in Hepatitis C Virus-Infected Patients Receiving Glecaprevir and Pibrentasvir in Japan

Supplemental material

Supplemental file 1 -
Supplemental Tables S1 and S2 and Figures S1 and S2
PDF, 115K